REFERENCES
1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in china, 2019. N Engl J Med. 2020;382:727-733.
2. Chen Z, Fan H, Cai J, et al. High-resolution computed tomography manifestations of COVID-19 infections in patients of different ages.Eur J Radiol . 2020;126:108972.
3. World Health Organization, Coronavirus Disease 2019 (COVID-19) Situation Report – 54, (2020) https://www.who.int/docs/default-source/coronaviruse/situationreports/20200408-sitrep-54-covid-19.pdf?sfvrsn=dcd46351_6.
4. Kim BS, Ko YH, Song PH, Kim TH, Kim KH, Kim BH. Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study.Prostate Int. 2019;7:30-34.
5. Peng YH, Huang CW, Chou CY, et al. Association between asthma and risk of benign prostatic hyperplasia: a retrospective population-based study. Aging Male. 2019;11:1-8.
6. World Health Organization. Situation Report 51, 2020 https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200311-sitrep-51-covid19.pdf
7. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020. doi: 10.1016/S1473-3099(20)30195-X.
8. Hou CP, Lin YH, Chen TH, et al. Transurethral resection of the prostate achieves favorable outcomes in stroke patients with symptomatic benign prostate hyperplasia. Aging Male. 2018;21:9-16.
9. Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of covid-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med. 2020. doi: 10.1164/rccm.202003-0543OC
10. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.Lancet. 2020;395:473-475.
11. Li Y, Zhang J, Wang N, et al. Therapeutic drugs targeting 2019-ncov main protease by high-throughput screening. bioRxiv. 2020. doi: 2020.01.28.922922.
12. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269-271.
13. Richardson P, Griffin I, Tucker C, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet.2020;395:e30-e31.
14. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in china. N Engl J Med. 2020. doi: 10.1056/NEJMoa2002032.
15. Li YK, Peng S, Li LQ, et al. Clinical and transmission characteristics of covid-19 - a retrospective study of 25 cases from a single thoracic surgery department. Curr Med Sci . 2020. doi: 10.1007/s11596-020-2176-2.
TABLE 1 Summary of characteristics, complications and outcome of patients with COVID-19